Titan Biotech Limited

BSE: 524717
Titan Biotech Limited - life sciences in Bhiwadi, Rajasthan, India. FY 2026 financials and compliance.
CIN L74999RJ1992PLC013387 Incorporated 18 February 1992 ROC Jaipur HQ Bhiwadi, Rajasthan, India
Active Listed - BSE: 524717 Public Limited Company life sciences
Data last updated
Revenue · FY 2026
₹206.19 Cr
▲ 31.79% YoY
Computed EBITDA · FY 2026
₹44.01 Cr
▲ 50.02% YoY
Net profit · FY 2026
₹29.89 Cr
▲ 38.8% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹8.26 Cr
Issued & subscribed
Open charges
₹21.19 Cr
Satisfied ₹37.52 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
377
Latest available

About Titan Biotech Limited

Data last updated: 15 July 2026

Titan Biotech Limited is a public limited company based in Bhiwadi, Rajasthan, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 18 February 1992, the company has been in operation for over 34 years.

Registered with ROC Jaipur under CIN L74999RJ1997PLC013387. Listed on BSE: 524717.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.26 Cr. Formerly known as Titan Medicares Limited and Titan Biotech Limited. It is led by directors including Manju Singla and Supriya Singla.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 902 A Riico.Indl.Area Phase – Iii, Bhiwadi, Rajasthan, India – 301019.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹206.19 Cr, a growth of 31.79% compared to the previous year. The net worth stands at ₹181.55 Cr (up 18.35% YoY). Total assets are valued at ₹213.88 Cr (up 22.42% YoY).

The company has a workforce of approximately 377 employees as per the latest available data.

The company is associated with 1 brand - Titan Biotech. As per MCA filings, the company has open charges of ₹21.19 Cr and satisfied charges of ₹37.52 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website titanbiotechltd.com.

Company Details of Titan Biotech Limited
CIN L74999RJ1992PLC013387
Registration Number 013387
Incorporation Date 18 February 1992
ROC Jaipur
Listing Status Listed (BSE: 524717)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Naresh Singla Managing Director Suresh Chand Singla Managing Director Raja Singla Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    A – 902 A Riico.Indl.Area Phase – Iii, Bhiwadi, Rajasthan, India – 301019
  • Industry
    Life Sciences, Biotechnology
Company report
Titan Biotech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Titan Biotech Limited report

Financials, compliance, directors, charges, ownership and filings for Titan Biotech Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Titan Biotech Limited

Titan Biotech Limited has undergone 2 name changes throughout its history. The company was previously known as Titan Medicares Limited, and Titan Biotech Limited. The current legal name is Titan Biotech Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Titan Biotech Limited Current
Titan Medicares Limited Previous

CIN History of Titan Biotech Limited

Titan Biotech Limited has one previous CIN (Corporate Identification Number): L74999RJ1997PLC013387. The current CIN is L74999RJ1992PLC013387, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74999RJ1992PLC013387 Current
L74999RJ1997PLC013387 Previous

Associated Brands with Titan Biotech Limited

Titan Biotech Limited operates one associated brand: Titan Biotech. These brands represent Titan Biotech Limited's diversified market presence and brand portfolio.

Brand Description Website
Titan Biotech
Biological products are manufactured and exported for various industries. titanbiotechltd.com

Competitors & Alternatives of Titan Biotech Limited

Brands and companies operating in the same space as Titan Biotech Limited include IPL Biologicals, Univia, Sri Biotech Laboratories and 6 more.

Competitor Description Location Founded
IPL Biologicals IPL Biologicals Plant nutrition and protection products are manufactured and supplied. Gurugram, India, India 1994
Univia Univia Agri-input retailers are connected to farmers via a phygital network. Ahmedabad, India, India 2020
Sri Biotech Laboratories Sri Biotech Laboratories Crop improvement research and nutrient manufacturing are conducted. Hyderabad, India, India 1994
Capsber Capsber Diversified crop biological solutions are provided for farmers. Bengaluru, India, India 2022
Absolute Absolute Biological technologies are developed for agriculture, healthcare, and materials science. Gurugram, India, India 2015
Lab2Land Lab2Land Agrochemicals, fertilizers, and crop nutrition solutions are researched and developed. Hyderabad, India, India 2020
Criyagen Criyagen Develops innovative technologies for organic and bio-active farm inputs. Bengaluru, India, India 2008
Shivashakthi BioTechnologies Shivashakthi BioTechnologies Development and commercial production of plantlets and farm inputs Hyderabad, India, India 2001
Varsha Bioscience and Technology Varsha Bioscience and Technology Bio-pesticides, bio-fertilizers, and plant growth promoters are manufactured. Hyderabad, India, India 2003

Business Activity of Titan Biotech Limited

Titan Biotech Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Titan Biotech Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Titan Biotech Limited

Titan Biotech Limited is audited by A N S K & Associates (ICAI peer reviewed, certificate valid till 2028-04-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
A N S K & Associates (ICAI peer reviewed, certificate valid till 2028-04-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Titan Biotech Limited

Titan Biotech Limited is currently managed by 12 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Manju Singla
Also directs: Titan Securities Limited, Peptech Biosciences Limited, Tanita Leasing & Finance Limited and 1 more
Director 23 Jun 2001 25 Years 0 Months Current
Supriya Singla
Also directs: Peptech Biosciences Limited, Titan Agritech Limited, Suptex Industries Private Limited and 4 more
Director 01 Oct 2012 13 Years 9 Months Current
Raja Singla
Also directs: Titan Agritech Limited, Satvik Realtech Llp, Snap House Llp and 4 more
Whole-Time Director 01 Oct 2022 3 Years 9 Months Current
Naresh Singla
Also directs: Titan Securities Limited, Titan Media Limited, Peptech Biosciences Limited and 4 more
Managing Director 01 May 2002 24 Years 2 Months Current
Suresh Chand Singla
Also directs: Titan Securities Limited, Titan Media Limited, Peptech Biosciences Limited and 5 more
Managing Director 01 Oct 2012 13 Years 9 Months Current
Rohit Jain
Also directs: Peptech Biosciences Limited, Singhania &Co- Llp, S&Co. (Ifsc) Llp and 5 more
Director 26 Jul 2021 4 Years 11 Months Current
Showing 6 of 12 current directors. View all directors

Financials of Titan Biotech Limited FY 2026 filings available

Titan Biotech Limited reported revenue of ₹206.19 Cr (up 31.79% YoY) for FY 2026.

Revenue · FY 2026
₹206.19 Cr ▲ 31.79%
Profit · FY 2026
₹29.89 Cr ▲ 38.8%
Computed EBITDA · FY 2026
₹44.01 Cr ▲ 50.02%
Revenue₹ Cr · Consolidated0100200300FY 2019: ₹65 Cr64.9FY 2019FY 2020: ₹79 Cr · +22.4% YoY79.4+22.4%FY 2020FY 2021: ₹142 Cr · +79.1% YoY142+79.1%FY 2021FY 2022: ₹153 Cr · +7.4% YoY153+7.4%FY 2022FY 2023: ₹144 Cr · -5.8% YoY144-5.8%FY 2023FY 2024: ₹164 Cr · +13.9% YoY164+13.9%FY 2024FY 2025: ₹156 Cr · -4.6% YoY156-4.6%FY 2025FY 2026: ₹206 Cr · +31.8% YoY206+31.8%FY 2026
Net Profit₹ Cr · Consolidated02040FY 2019: ₹4 Cr3.9FY 2019FY 2020: ₹8 Cr · +100.3% YoY7.8+100.3%FY 2020FY 2021: ₹32 Cr · +304.5% YoY31.7+304.5%FY 2021FY 2022: ₹29 Cr · -9.3% YoY28.7-9.3%FY 2022FY 2023: ₹25 Cr · -13.6% YoY24.8-13.6%FY 2023FY 2024: ₹25 Cr · +0% YoY24.9+0%FY 2024FY 2025: ₹22 Cr · -13.4% YoY21.5-13.4%FY 2025FY 2026: ₹30 Cr · +38.8% YoY29.9+38.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0204060Q1'25: ₹43 Cr43.1Q1'25Q2'25: ₹40 Cr39.9Q2'25Q3'25: ₹38 Cr38.3Q3'25Q4'25: ₹35 Cr35.2Q4'25Q1'26: ₹46 Cr · +7.8% YoY46.5+7.8%Q1'26Q2'26: ₹54 Cr · +36.3% YoY54.4+36.3%Q2'26Q3'26: ₹57 Cr · +47.6% YoY56.5+47.6%Q3'26Q4'26: ₹49 Cr · +38.9% YoY48.8+38.9%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹206.19 Cr ₹156.45 Cr ₹164.07 Cr ₹144 Cr ₹152.81 Cr ₹142.24 Cr ₹79.44 Cr ₹64.91 Cr
Other Income ₹5.41 Cr ₹3.91 Cr ₹1.75 Cr ₹1.94 Cr ₹1.02 Cr ₹78.84 Lakh ₹44.95 Lakh ₹68.65 Lakh
Total Income ₹211.6 Cr ₹160.36 Cr ₹165.82 Cr ₹145.94 Cr ₹153.83 Cr ₹143.03 Cr ₹79.89 Cr ₹65.59 Cr
Cost of Materials Consumed ₹99.16 Cr ₹75.48 Cr ₹80.89 Cr ₹70.81 Cr ₹75.48 Cr ₹67.3 Cr ₹40.24 Cr ₹36.55 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹2.97 Cr -₹2.85 Cr -₹5.29 Cr -₹93.21 Lakh -₹60.16 Lakh -₹2.73 Cr -₹89.24 Lakh -₹3.85 Cr
Employee Benefit Expense ₹32.36 Cr ₹26.38 Cr ₹23.71 Cr ₹18.21 Cr ₹16.14 Cr ₹14.05 Cr ₹12.47 Cr ₹10.27 Cr
Finance Costs ₹91.39 Lakh ₹80.18 Lakh ₹1.17 Cr ₹74.59 Lakh ₹1.28 Cr ₹1.67 Cr ₹2.34 Cr ₹2.29 Cr
Depreciation & Amortisation ₹4.93 Cr ₹4.17 Cr ₹3.33 Cr ₹2.6 Cr ₹2.54 Cr ₹2.22 Cr ₹1.8 Cr ₹1.71 Cr
Other Expenses ₹39.03 Cr ₹32.02 Cr ₹30.47 Cr ₹26.4 Cr ₹20.8 Cr ₹17.49 Cr ₹14.14 Cr ₹13.08 Cr
Total Expenses ₹173.43 Cr ₹136 Cr ₹134.29 Cr ₹117.83 Cr ₹115.63 Cr ₹100 Cr ₹70.1 Cr ₹60.05 Cr
Profit Before Exceptional Items & Tax ₹38.17 Cr ₹24.37 Cr ₹31.53 Cr ₹28.12 Cr ₹38.2 Cr ₹43.03 Cr ₹9.79 Cr ₹5.54 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 -₹32.44 Lakh ₹61.41 Lakh ₹0
Profit Before Tax ₹38.17 Cr ₹24.37 Cr ₹31.53 Cr ₹28.12 Cr ₹38.2 Cr ₹42.71 Cr ₹10.4 Cr ₹5.54 Cr
Total Tax Expense ₹10.73 Cr ₹6.1 Cr ₹7.87 Cr ₹7.09 Cr ₹9.65 Cr ₹11 Cr ₹2.57 Cr ₹1.63 Cr
Net Profit ₹29.89 Cr ₹21.53 Cr ₹24.85 Cr ₹24.84 Cr ₹28.74 Cr ₹31.71 Cr ₹7.84 Cr ₹3.91 Cr
  attributable to Owners - - - - - - ₹7.07 Cr -
  attributable to NCI - - - - - - ₹77.16 Lakh -
Other Comprehensive Income -₹8.82 Lakh ₹7.3 Lakh ₹17.48 Lakh ₹0 ₹0 ₹5.21 Lakh -₹5.02 Lakh ₹9.78 Lakh
Total Comprehensive Income ₹29.8 Cr ₹21.6 Cr ₹25.03 Cr ₹24.84 Cr ₹28.74 Cr ₹31.76 Cr ₹7.79 Cr ₹4.01 Cr
EBITDA (computed) ₹44.01 Cr ₹29.34 Cr ₹36.03 Cr ₹31.46 Cr ₹42.02 Cr ₹46.91 Cr ₹13.93 Cr ₹9.55 Cr
Basic EPS ₹7.23 ₹26.06 ₹28.64 ₹30.06 ₹30.66 ₹36.71 ₹8.55 ₹0.80
Diluted EPS ₹7.23 ₹26.06 ₹28.64 ₹30.06 ₹30.66 ₹36.71 ₹8.55 ₹0.80
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹213.88 Cr ₹174.71 Cr ₹156.58 Cr ₹134.52 Cr ₹143.4 Cr ₹100.72 Cr ₹76.04 Cr ₹64.73 Cr
Non-current Assets ₹128.64 Cr ₹95.67 Cr ₹84.41 Cr ₹66.21 Cr ₹52.05 Cr ₹41.39 Cr ₹31.84 Cr ₹29.59 Cr
Current Assets ₹85.24 Cr ₹79.04 Cr ₹72.17 Cr ₹68.31 Cr ₹91.35 Cr ₹59.33 Cr ₹44.2 Cr ₹35.14 Cr
Property, Plant & Equipment ₹51.34 Cr ₹57.16 Cr ₹51.94 Cr ₹35.81 Cr ₹42.05 Cr ₹33.52 Cr ₹31.06 Cr ₹28.92 Cr
Inventories ₹55.77 Cr ₹50.72 Cr ₹45.57 Cr ₹36.17 Cr ₹42.29 Cr ₹32.54 Cr ₹27.98 Cr ₹21.13 Cr
Trade Receivables ₹22.83 Cr ₹18.82 Cr ₹18.66 Cr ₹21.01 Cr ₹21.67 Cr ₹18.1 Cr ₹11.86 Cr ₹9.24 Cr
Cash & Equivalents ₹1.48 Cr ₹5.13 Cr ₹2.84 Cr ₹4.86 Cr ₹15.61 Cr ₹5.45 Cr ₹1.83 Cr ₹1.87 Cr
Equity (Net Worth) ₹181.55 Cr ₹153.4 Cr ₹133.45 Cr ₹109.91 Cr ₹105.41 Cr ₹72.48 Cr ₹41.55 Cr ₹33.76 Cr
Equity Share Capital ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr
Borrowings (Non-current) ₹32.67 Lakh ₹18.43 Lakh ₹45.33 Lakh ₹29.9 Lakh ₹8.4 Cr ₹4.86 Cr ₹11.55 Cr ₹13.17 Cr
Borrowings (Current) ₹3.34 Cr ₹1.92 Cr ₹6.72 Cr ₹6.7 Cr ₹7.47 Cr ₹8.29 Cr ₹11.34 Cr ₹9.68 Cr
Total Debt (computed) ₹3.67 Cr ₹2.1 Cr ₹7.17 Cr ₹7 Cr ₹15.87 Cr ₹13.14 Cr ₹22.89 Cr ₹22.84 Cr
Current Liabilities ₹25.96 Cr ₹17.74 Cr ₹19.13 Cr ₹20.35 Cr ₹25.23 Cr ₹19.11 Cr ₹20.43 Cr ₹15.78 Cr
Total Liabilities ₹32.34 Cr ₹21.3 Cr ₹23.13 Cr ₹24.6 Cr ₹37.99 Cr ₹28.24 Cr ₹34.49 Cr ₹30.97 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹30.42 Cr ₹20.12 Cr ₹21.15 Cr ₹21.18 Cr ₹22.86 Cr
Investing Cash Flow -₹34.41 Cr -₹9.87 Cr -₹20.3 Cr -₹20.73 Cr -₹18.79 Cr
Financing Cash Flow ₹34.39 Lakh -₹7.96 Cr -₹2.87 Cr -₹2.4 Cr ₹6.08 Cr
Capital Expenditure ₹9.31 Cr ₹9.39 Cr ₹8.71 Cr ₹13.17 Cr ₹18.79 Cr
Free Cash Flow (computed) ₹21.11 Cr ₹10.73 Cr ₹12.44 Cr ₹8.01 Cr ₹4.07 Cr
Dividends Paid ₹1.65 Cr ₹1.65 Cr ₹1.49 Cr ₹1.24 Cr ₹1.24 Cr
Net Change in Cash -₹3.65 Cr ₹2.29 Cr -₹2.02 Cr -₹1.95 Cr ₹10.16 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹48.83 Cr ₹56.51 Cr ₹54.35 Cr ₹46.5 Cr ₹35.17 Cr ₹38.28 Cr ₹39.89 Cr ₹43.11 Cr
Other Income ₹2.11 Cr ₹1.26 Cr ₹1.32 Cr ₹72.22 Lakh ₹1.38 Cr ₹1.59 Cr ₹31.86 Lakh ₹62.37 Lakh
Total Income ₹50.94 Cr ₹57.76 Cr ₹55.68 Cr ₹47.22 Cr ₹36.55 Cr ₹39.87 Cr ₹40.21 Cr ₹43.74 Cr
Cost of Materials Consumed ₹25.91 Cr ₹27.28 Cr ₹27.43 Cr ₹18.55 Cr ₹17.3 Cr ₹19.64 Cr ₹16.19 Cr ₹22.35 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹7.08 Cr ₹9.12 Lakh -₹1.38 Cr ₹5.4 Cr -₹2.29 Cr -₹1.3 Cr ₹1.32 Cr -₹57.87 Lakh
Employee Benefit Expense ₹9.44 Cr ₹8.53 Cr ₹7.38 Cr ₹7.01 Cr ₹6.94 Cr ₹6.67 Cr ₹6.5 Cr ₹6.27 Cr
Finance Costs ₹23.72 Lakh ₹25.74 Lakh ₹22.41 Lakh ₹19.52 Lakh ₹7.88 Lakh ₹14.85 Lakh ₹26.55 Lakh ₹30.9 Lakh
Depreciation & Amortisation ₹1.3 Cr ₹1.27 Cr ₹1.21 Cr ₹1.15 Cr ₹84.33 Lakh ₹1.18 Cr ₹1.1 Cr ₹1.05 Cr
Other Expenses ₹10.86 Cr ₹9.78 Cr ₹11.6 Cr ₹6.8 Cr ₹8.64 Cr ₹8.43 Cr ₹8.12 Cr ₹6.83 Cr
Total Expenses ₹40.66 Cr ₹47.2 Cr ₹46.46 Cr ₹39.11 Cr ₹31.52 Cr ₹34.76 Cr ₹33.49 Cr ₹36.22 Cr
Profit Before Exceptional Items & Tax ₹10.28 Cr ₹10.56 Cr ₹9.22 Cr ₹8.11 Cr ₹5.03 Cr ₹5.1 Cr ₹6.72 Cr ₹7.52 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹10.28 Cr ₹10.56 Cr ₹9.22 Cr ₹8.11 Cr ₹5.03 Cr ₹5.1 Cr ₹6.72 Cr ₹7.52 Cr
Total Tax Expense ₹3.73 Cr ₹2.69 Cr ₹2.36 Cr ₹1.95 Cr ₹1.26 Cr ₹1.3 Cr ₹1.71 Cr ₹1.82 Cr
Net Profit ₹6.73 Cr ₹8.53 Cr ₹7.76 Cr ₹6.86 Cr ₹4.05 Cr ₹4.39 Cr ₹6.7 Cr ₹6.4 Cr
  attributable to Owners - - ₹0 ₹0 - - - -
  attributable to NCI - - ₹0 ₹0 - - - -
Other Comprehensive Income -₹14.3 Lakh ₹1.83 Lakh ₹1.82 Lakh ₹1.83 Lakh -₹5.81 Lakh ₹4.37 Lakh ₹4.37 Lakh ₹4.37 Lakh
Total Comprehensive Income ₹6.59 Cr ₹8.55 Cr ₹7.78 Cr ₹6.88 Cr ₹3.99 Cr ₹4.43 Cr ₹6.74 Cr ₹6.44 Cr
EBITDA (computed) ₹11.82 Cr ₹12.09 Cr ₹10.65 Cr ₹9.46 Cr ₹5.95 Cr ₹6.44 Cr ₹8.08 Cr ₹8.87 Cr
Basic EPS ₹1.63 ₹10.32 ₹9.40 ₹8.30 ₹4.90 ₹5.31 ₹8.10 ₹7.74
Diluted EPS ₹1.63 ₹10.32 ₹9.40 ₹8.30 ₹4.90 ₹5.31 ₹8.10 ₹7.74
Latest 8 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹206.19 Cr ₹156.45 Cr ₹164.07 Cr ₹144 Cr ₹123.55 Cr ₹122.46 Cr ₹69.48 Cr ₹58.24 Cr
Other Income ₹5.41 Cr ₹3.91 Cr ₹1.75 Cr ₹1.94 Cr ₹94.13 Lakh ₹65.99 Lakh ₹40.95 Lakh ₹65.14 Lakh
Total Income ₹211.6 Cr ₹160.36 Cr ₹165.82 Cr ₹145.94 Cr ₹124.49 Cr ₹123.12 Cr ₹69.89 Cr ₹58.89 Cr
Cost of Materials Consumed ₹99.16 Cr ₹75.48 Cr ₹80.89 Cr ₹70.81 Cr ₹59.12 Cr ₹55.54 Cr ₹36.74 Cr ₹34.5 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹2.97 Cr -₹2.85 Cr -₹5.29 Cr -₹93.21 Lakh -₹17.3 Lakh -₹2.23 Cr -₹65.44 Lakh -₹3.88 Cr
Employee Benefit Expense ₹32.36 Cr ₹26.38 Cr ₹23.71 Cr ₹18.21 Cr ₹14.33 Cr ₹12.04 Cr ₹10.03 Cr ₹8.49 Cr
Finance Costs ₹91.39 Lakh ₹80.18 Lakh ₹1.17 Cr ₹74.59 Lakh ₹78.39 Lakh ₹1.28 Cr ₹1.9 Cr ₹2.04 Cr
Depreciation & Amortisation ₹4.93 Cr ₹4.17 Cr ₹3.33 Cr ₹2.6 Cr ₹2.37 Cr ₹2.1 Cr ₹1.75 Cr ₹1.68 Cr
Other Expenses ₹39.03 Cr ₹32.02 Cr ₹30.47 Cr ₹26.4 Cr ₹19.09 Cr ₹15.3 Cr ₹12.5 Cr ₹11.72 Cr
Total Expenses ₹173.43 Cr ₹136 Cr ₹134.29 Cr ₹117.83 Cr ₹95.52 Cr ₹84.03 Cr ₹62.26 Cr ₹54.54 Cr
Profit Before Exceptional Items & Tax ₹38.17 Cr ₹24.37 Cr ₹31.53 Cr ₹28.12 Cr ₹28.97 Cr ₹39.09 Cr ₹7.63 Cr ₹4.36 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 -₹32.44 Lakh ₹61.41 Lakh ₹0
Profit Before Tax ₹38.17 Cr ₹24.37 Cr ₹31.53 Cr ₹28.12 Cr ₹28.97 Cr ₹38.76 Cr ₹8.24 Cr ₹4.36 Cr
Total Tax Expense ₹10.73 Cr ₹6.1 Cr ₹7.87 Cr ₹7.09 Cr ₹7.28 Cr ₹9.99 Cr ₹2.04 Cr ₹1.28 Cr
Net Profit ₹27.45 Cr ₹18.27 Cr ₹23.66 Cr ₹21.02 Cr ₹21.68 Cr ₹28.77 Cr ₹6.2 Cr ₹3.08 Cr
Other Comprehensive Income -₹8.65 Lakh ₹7.3 Lakh ₹17.48 Lakh ₹0 -₹2.08 Lakh ₹6.04 Lakh -₹4.71 Lakh ₹9.61 Lakh
Total Comprehensive Income ₹27.36 Cr ₹18.34 Cr ₹23.84 Cr ₹21.02 Cr ₹21.66 Cr ₹28.83 Cr ₹6.15 Cr ₹3.18 Cr
EBITDA (computed) ₹44.01 Cr ₹29.34 Cr ₹36.03 Cr ₹31.46 Cr ₹32.12 Cr ₹42.47 Cr ₹11.27 Cr ₹8.07 Cr
Basic EPS ₹6.64 ₹22.11 ₹28.64 ₹25.44 ₹26.24 ₹34.82 ₹7.51 ₹3.73
Diluted EPS ₹6.64 ₹22.11 ₹28.64 ₹25.44 ₹26.24 ₹34.82 ₹7.51 ₹3.73
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹203.18 Cr ₹174.71 Cr ₹151.57 Cr ₹130.7 Cr ₹107.56 Cr ₹86.17 Cr ₹65.2 Cr ₹59.82 Cr
Non-current Assets ₹117.94 Cr ₹95.67 Cr ₹79.4 Cr ₹62.39 Cr ₹44.34 Cr ₹36.03 Cr ₹27.09 Cr ₹27.74 Cr
Current Assets ₹85.24 Cr ₹79.04 Cr ₹72.17 Cr ₹68.31 Cr ₹63.23 Cr ₹50.14 Cr ₹38.11 Cr ₹32.07 Cr
Property, Plant & Equipment ₹51.34 Cr ₹57.16 Cr ₹51.94 Cr ₹35.81 Cr ₹34.88 Cr ₹26.95 Cr ₹25.14 Cr ₹25.81 Cr
Inventories ₹55.77 Cr ₹50.72 Cr ₹45.57 Cr ₹36.17 Cr ₹34.68 Cr ₹26.83 Cr ₹24.14 Cr ₹19.96 Cr
Trade Receivables ₹22.83 Cr ₹18.82 Cr ₹18.66 Cr ₹21.01 Cr ₹16.36 Cr ₹16.12 Cr ₹10.54 Cr ₹7.84 Cr
Cash & Equivalents ₹1.48 Cr ₹5.13 Cr ₹2.84 Cr ₹4.86 Cr ₹6.81 Cr ₹5.31 Cr ₹1.7 Cr ₹1.59 Cr
Equity (Net Worth) ₹170.84 Cr ₹153.4 Cr ₹128.44 Cr ₹106.09 Cr ₹86.24 Cr ₹65.82 Cr ₹37.81 Cr ₹31.66 Cr
Equity Share Capital ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr ₹8.26 Cr
Borrowings (Non-current) ₹32.67 Lakh ₹18.43 Lakh ₹45.33 Lakh ₹29.9 Lakh ₹1.08 Cr ₹1.83 Cr ₹8.48 Cr ₹12.02 Cr
Borrowings (Current) ₹3.34 Cr ₹1.92 Cr ₹6.72 Cr ₹6.7 Cr ₹4.72 Cr ₹5.71 Cr ₹8.41 Cr ₹8.84 Cr
Total Debt (computed) ₹3.67 Cr ₹2.1 Cr ₹7.17 Cr ₹7 Cr ₹5.8 Cr ₹7.54 Cr ₹16.89 Cr ₹20.85 Cr
Current Liabilities ₹25.96 Cr ₹17.74 Cr ₹19.13 Cr ₹20.35 Cr ₹16.42 Cr ₹14.37 Cr ₹16.47 Cr ₹14.16 Cr
Total Liabilities ₹32.34 Cr ₹21.3 Cr ₹23.13 Cr ₹24.6 Cr ₹21.32 Cr ₹20.35 Cr ₹27.39 Cr ₹28.16 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹30.42 Cr ₹20.12 Cr ₹21.15 Cr ₹21.18 Cr ₹21.95 Cr
Investing Cash Flow -₹34.41 Cr -₹9.87 Cr -₹20.3 Cr -₹20.73 Cr -₹16.44 Cr
Financing Cash Flow ₹34.39 Lakh -₹7.96 Cr -₹2.87 Cr -₹2.4 Cr -₹4.01 Cr
Capital Expenditure ₹9.31 Cr ₹9.39 Cr ₹8.71 Cr ₹13.17 Cr ₹13.68 Cr
Free Cash Flow (computed) ₹21.11 Cr ₹10.73 Cr ₹12.44 Cr ₹8.01 Cr ₹8.27 Cr
Dividends Paid ₹1.65 Cr ₹1.65 Cr ₹1.49 Cr ₹1.24 Cr ₹1.24 Cr
Net Change in Cash -₹3.65 Cr ₹2.29 Cr -₹2.02 Cr -₹1.95 Cr ₹1.51 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹48.83 Cr ₹56.51 Cr ₹54.35 Cr ₹46.5 Cr ₹35.17 Cr ₹38.28 Cr ₹39.89 Cr ₹43.11 Cr
Other Income ₹2.11 Cr ₹1.26 Cr ₹1.32 Cr ₹72.22 Lakh ₹1.38 Cr ₹1.59 Cr ₹31.86 Lakh ₹62.37 Lakh
Total Income ₹50.94 Cr ₹57.76 Cr ₹55.68 Cr ₹47.22 Cr ₹36.55 Cr ₹39.87 Cr ₹40.21 Cr ₹43.74 Cr
Cost of Materials Consumed ₹25.91 Cr ₹27.28 Cr ₹27.43 Cr ₹18.55 Cr ₹17.3 Cr ₹19.64 Cr ₹16.19 Cr ₹22.35 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹7.08 Cr ₹9.12 Lakh -₹1.38 Cr ₹5.4 Cr -₹2.29 Cr -₹1.3 Cr ₹1.32 Cr -₹57.87 Lakh
Employee Benefit Expense ₹9.44 Cr ₹8.53 Cr ₹7.38 Cr ₹7.01 Cr ₹6.94 Cr ₹6.67 Cr ₹6.5 Cr ₹6.27 Cr
Finance Costs ₹23.72 Lakh ₹25.74 Lakh ₹22.41 Lakh ₹19.52 Lakh ₹7.88 Lakh ₹14.85 Lakh ₹26.55 Lakh ₹30.9 Lakh
Depreciation & Amortisation ₹1.3 Cr ₹1.27 Cr ₹1.21 Cr ₹1.15 Cr ₹84.33 Lakh ₹1.18 Cr ₹1.1 Cr ₹1.05 Cr
Other Expenses ₹10.86 Cr ₹9.78 Cr ₹11.6 Cr ₹6.8 Cr ₹8.64 Cr ₹8.43 Cr ₹8.12 Cr ₹6.83 Cr
Total Expenses ₹40.66 Cr ₹47.2 Cr ₹46.46 Cr ₹39.11 Cr ₹31.52 Cr ₹34.76 Cr ₹33.49 Cr ₹36.22 Cr
Profit Before Exceptional Items & Tax ₹10.28 Cr ₹10.56 Cr ₹9.22 Cr ₹8.11 Cr ₹5.03 Cr ₹5.1 Cr ₹6.72 Cr ₹7.52 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹10.28 Cr ₹10.56 Cr ₹9.22 Cr ₹8.11 Cr ₹5.03 Cr ₹5.1 Cr ₹6.72 Cr ₹7.52 Cr
Total Tax Expense ₹3.73 Cr ₹2.69 Cr ₹2.36 Cr ₹1.95 Cr ₹1.26 Cr ₹1.3 Cr ₹1.71 Cr ₹1.82 Cr
Net Profit ₹6.56 Cr ₹7.87 Cr ₹6.86 Cr ₹6.16 Cr ₹3.77 Cr ₹3.8 Cr ₹5 Cr ₹5.7 Cr
Other Comprehensive Income -₹14.13 Lakh ₹1.83 Lakh ₹1.82 Lakh ₹1.83 Lakh -₹5.81 Lakh ₹4.37 Lakh ₹4.37 Lakh ₹4.37 Lakh
Total Comprehensive Income ₹6.41 Cr ₹7.89 Cr ₹6.88 Cr ₹6.18 Cr ₹3.71 Cr ₹3.85 Cr ₹5.05 Cr ₹5.74 Cr
EBITDA (computed) ₹11.82 Cr ₹12.09 Cr ₹10.65 Cr ₹9.46 Cr ₹5.95 Cr ₹6.44 Cr ₹8.08 Cr ₹8.87 Cr
Basic EPS ₹1.59 ₹9.52 ₹8.30 ₹7.46 ₹4.56 ₹4.60 ₹6.05 ₹6.90
Diluted EPS ₹1.59 ₹9.52 ₹8.30 ₹7.46 ₹4.56 ₹4.60 ₹6.05 ₹6.90
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Titan Biotech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Charges & Borrowings of Titan Biotech Limited

Open charges
₹21.19 Cr
Satisfied charges
₹37.52 Cr
Breakdown by lending institutions
Others₹17.00 Cr
Hdfc Bank Limited₹4.19 Cr
Latest charge details
DateLenderAmountStatus
30 Oct 2025 Hdfc Bank Limited ₹45 Lakh Open
30 Dec 2024 Others ₹17 Cr Open
13 Dec 2024 Hdfc Bank Limited ₹3.02 Cr Open
12 Aug 2024 Hdfc Bank Limited ₹12 Lakh Open
21 Jul 2022 Hdfc Bank Limited ₹45 Lakh Open

Total charge records: 10 View all charges

Employees and EPFO Compliance at Titan Biotech Limited

View historical data on people associated with Titan Biotech Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Titan Biotech Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Titan Biotech Limited

Premium access

GST registrations and filing compliance for Titan Biotech Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Titan Biotech Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Titan Biotech Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Titan Biotech Limited

Premium access

MSME payment history for Titan Biotech Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Titan Biotech Limited

Premium access

Corporate group structure for Titan Biotech Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Titan Biotech Limited

Premium access

MCA filings and documents for Titan Biotech Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Titan Biotech Limited

Charges
30 Oct 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101200775 was registered on 30 Oct 2025.
Activity
26 Sep 2025
Titan Biotech Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Directors
13 Aug 2025
Debendra Kumar Sabat was appointed as a Director on 13 Aug 2025 & has been associated with this company since 11 months 8 days.
Charges
22 Jul 2025
A charge with Hdfc Bank Limited of Rs. 3.02 Cr registered on 13 Dec 2024 with Charge ID 101038017 was modified on 22 Jul 2025.
Activity
31 Mar 2025
Titan Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
14 Jan 2025
A charge registered on 08 Sep 2022 via Charge ID 100646281 with Hdfc Bank Limited was fully satisfied on 14 Jan 2025.

Recent News on Titan Biotech Limited

Frequently Asked Questions about Titan Biotech Limited

Titan Biotech Limited is an active public limited company in the life sciences sector based in Bhiwadi, Rajasthan, India. It was incorporated on 18 February 1992 (34+ years old) and is registered under CIN L74999RJ1992PLC013387. Listed on BSE: 524717. The company has 377 employees.

Titan Biotech Limited reported revenue of ₹206.19 Cr for FY 2026 (up 31.79% YoY) based on consolidated BSE filings.

The current directors of Titan Biotech Limited are:

The primary industry of Titan Biotech Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Yes. Titan Biotech Limited is listed on BSE with code 524717.

Titan Biotech Limited can be reached at the registered office: A – 902 A Riico.Indl.Area Phase – Iii, Bhiwadi, Rajasthan, India – 301019, or through the website titanbiotechltd.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available